company background image
6869 logo

Sysmex TSE:6869 Stock Report

Last Price

JP¥2.94k

Market Cap

JP¥1.8t

7D

-2.5%

1Y

14.1%

Updated

19 Dec, 2024

Data

Company Financials +

6869 Stock Overview

Engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. More details

6869 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance5/6
Financial Health5/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 6869 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Sysmex Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sysmex
Historical stock prices
Current Share PriceJP¥2,935.00
52 Week HighJP¥3,236.00
52 Week LowJP¥2,138.00
Beta0.63
1 Month Change-6.47%
3 Month Change3.80%
1 Year Change14.10%
3 Year Change-42.86%
5 Year Change17.56%
Change since IPO2,835.00%

Recent News & Updates

Recent updates

Sysmex Corporation (TSE:6869) Not Lagging Market On Growth Or Pricing

Dec 10
Sysmex Corporation (TSE:6869) Not Lagging Market On Growth Or Pricing

Estimating The Fair Value Of Sysmex Corporation (TSE:6869)

Nov 23
Estimating The Fair Value Of Sysmex Corporation (TSE:6869)

Results: Sysmex Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts

Nov 10
Results: Sysmex Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts

Here's Why Sysmex (TSE:6869) Can Manage Its Debt Responsibly

Nov 03
Here's Why Sysmex (TSE:6869) Can Manage Its Debt Responsibly

Does Sysmex (TSE:6869) Deserve A Spot On Your Watchlist?

Oct 21
Does Sysmex (TSE:6869) Deserve A Spot On Your Watchlist?

Sysmex's (TSE:6869) Returns On Capital Not Reflecting Well On The Business

Sep 18
Sysmex's (TSE:6869) Returns On Capital Not Reflecting Well On The Business

After Leaping 26% Sysmex Corporation (TSE:6869) Shares Are Not Flying Under The Radar

Sep 04
After Leaping 26% Sysmex Corporation (TSE:6869) Shares Are Not Flying Under The Radar

Sysmex Corporation Just Recorded A 7.1% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 08
Sysmex Corporation Just Recorded A 7.1% EPS Beat: Here's What Analysts Are Forecasting Next

A Look At The Intrinsic Value Of Sysmex Corporation (TSE:6869)

Jul 27
A Look At The Intrinsic Value Of Sysmex Corporation (TSE:6869)

Sysmex Corporation's (TSE:6869) Business Is Yet to Catch Up With Its Share Price

Jun 12
Sysmex Corporation's (TSE:6869) Business Is Yet to Catch Up With Its Share Price

Results: Sysmex Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

May 12
Results: Sysmex Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

These 4 Measures Indicate That Sysmex (TSE:6869) Is Using Debt Reasonably Well

Apr 27
These 4 Measures Indicate That Sysmex (TSE:6869) Is Using Debt Reasonably Well

Sysmex Corporation's (TSE:6869) P/E Is On The Mark

Feb 28
Sysmex Corporation's (TSE:6869) P/E Is On The Mark

Shareholder Returns

6869JP Medical EquipmentJP Market
7D-2.5%-1.3%-0.9%
1Y14.1%13.7%13.7%

Return vs Industry: 6869 matched the JP Medical Equipment industry which returned 13.7% over the past year.

Return vs Market: 6869 matched the JP Market which returned 13.7% over the past year.

Price Volatility

Is 6869's price volatile compared to industry and market?
6869 volatility
6869 Average Weekly Movement3.7%
Medical Equipment Industry Average Movement3.5%
Market Average Movement3.6%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market1.9%

Stable Share Price: 6869 has not had significant price volatility in the past 3 months compared to the JP market.

Volatility Over Time: 6869's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196810,042n/awww.sysmex.co.jp

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Sysmex Corporation Fundamentals Summary

How do Sysmex's earnings and revenue compare to its market cap?
6869 fundamental statistics
Market capJP¥1.84t
Earnings (TTM)JP¥53.46b
Revenue (TTM)JP¥491.29b

34.2x

P/E Ratio

3.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6869 income statement (TTM)
RevenueJP¥491.29b
Cost of RevenueJP¥228.51b
Gross ProfitJP¥262.78b
Other ExpensesJP¥209.32b
EarningsJP¥53.46b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 12, 2025

Earnings per share (EPS)85.73
Gross Margin53.49%
Net Profit Margin10.88%
Debt/Equity Ratio7.1%

How did 6869 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

34%

Payout Ratio

Does 6869 pay a reliable dividends?

See 6869 dividend history and benchmarks
When do you need to buy 6869 by to receive an upcoming dividend?
Sysmex dividend dates
Ex Dividend DateMar 28 2025
Dividend Pay DateJun 24 2025
Days until Ex dividend99 days
Days until Dividend pay date187 days

Does 6869 pay a reliable dividends?

See 6869 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 09:40
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sysmex Corporation is covered by 35 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yoshitsugu SasakiAizawa Securities Co. Ltd.
Masahiro NakanomyoBarclays
Craig NelsonBNP Paribas Securities (Asia)